At Kendle, we have a global, integrated late phase team consisting of experienced biopharmaceutical industry and clinical development professionals who deliver proactive, creative and collaborative late phase study solutions. With our wealth of experience, we are able to rigorously pursue your commercialization objectives while ensuring your regulatory and scientific obligations are met. We will look for opportunities for your product that you may not have even considered.
Our late phase teams are supported by our experienced regulatory affairs professionals who can guide you through the complex country-specific regulatory environments.
Our international network allows us to leverage our global resources to ensure we have the capacity, infrastructure, experience and capability to conduct almost any late phase project in any geographic region. Our local expertise ensures we understand intimately the customs, language and regulatory requirements of all regions where we operate.

- Vision to see what’s possible
- Inspiration to find creative solutions
- Patient education
- And the proactivity to deliver in real-world settings…
…That’s the difference real people bring
|